Apr 05
Novozymes and Boehringer Ingelheim Announce Strategic Collaboration in Probiotics for Poultry Hatcheries
Duluth, U.S. & Copenhagen, Denmark – March 30, 2017 – Boehringer Ingelheim Animal Health and Novozymes today announced a strategic collaboration to develop and commercialize probiotics for global poultry production. The parties will focus on developing products for hatcheries, the facilities where eggs are hatched before the chickens move to grow-out farms. As part of the agreement, Boehringer Ingelheim will market and distribute Novozymes’ FloraMax® probiotic product for the U.S. poultry industry. Boehringer Ingelheim plans on expanding to other markets globally in the coming years.